Bis zu 50 % günstiger als neu 3 Jahre rebuy Garantie Professionelles Refurbishment
ElektronikMedien
Tipps & News
AppleAlle anzeigen
TabletsAlle anzeigen
HandyAlle anzeigen
Fairphone
AppleAlle anzeigen
iPhone Air Generation
GoogleAlle anzeigen
Pixel Fold
HonorAlle anzeigen
NothingAlle anzeigen
OnePlusAlle anzeigen
OnePlus 11 GenerationOnePlus 12 GenerationOnePlus 5 GenerationOnePlus 6 GenerationWeitere Modelle
SamsungAlle anzeigen
Galaxy XcoverWeitere Modelle
SonyAlle anzeigen
Weitere ModelleXperia LXperia MXperia X
XiaomiAlle anzeigen
Weitere Modelle
Tablets & eBook ReaderAlle anzeigen
Google
AppleAlle anzeigen
Zubehör
HuaweiAlle anzeigen
MatePad Pro Serie
XiaomiAlle anzeigen
Kameras & ZubehörAlle anzeigen
Kamera Bundles
ObjektiveAlle anzeigen
ZEISS
System & SpiegelreflexAlle anzeigen
Leica
WearablesAlle anzeigen
SmartwatchesAlle anzeigen
LGMotorolaSonyXiaomi
Konsolen & ZubehörAlle anzeigen
Lenovo Legion GoMSI Claw
NintendoAlle anzeigen
Nintendo Game Boy ClassicNintendo Switch Lite
PlayStationAlle anzeigen
XboxAlle anzeigen
Audio & HiFiAlle anzeigen
Zubehör
iPodAlle anzeigen
Zubehör

Handgeprüfte Gebrauchtware

Bis zu 50 % günstiger als neu

Der Umwelt zuliebe

A Practical Guide to Drug Development in Academia

(Broschiert, Englisch)

Keine Bewertungen vorhanden
Optischer Zustand
Beschreibung
"A lot of hard-won knowledge is laid out here in a brief but informative way. Every topic is well referenced, with citations from both the primary literature and relevant resources from the internet." Review of first edition from Nature Chemical Biology Written by the founders of the SPARK program at Stanford University, this book is a practical guide designed for professors, students and clinicians at academic research institutions who are interested in learning more about the drug development process and how to start transforming their basic research discoveries into novel drugs. Often many potentially transformative basic science discoveries are not pursued because they are deemed ‘too early’ to attract industry interest. This comprehensive book lays out simple, relatively cost-effective things that academic researchers can do to advance their findings to the point that they can be tested in the clinic or attract more industry interest. Each chapter broadly discusses an important topic in drug development, from discovery, optimization and preclinical studies through clinical trial design, regulatory issues and marketing assessments. After the practical overview provided here, the reader is encouraged to consult more detailed texts on specific topics of interest. The SPARK model has been adopted in over 60 institutions on six continents, and the program has been honored with multiple awards including the 2020 Xconomy Award for Ecosystem Development, the 2020 Cures Within Reach Award for Patient Impact Research, and the 2022 California Life Sciences Pantheon Award for Academia, Non-Profits, & Research. The new edition updates every chapter with the latest developments since the 2014 publication of the first edition.
Dieses Produkt haben wir gerade leider nicht auf Lager.
ab 28,99 €
Derzeit nicht verfügbar
Derzeit nicht verfügbar

Handgeprüfte Gebrauchtware

Bis zu 50 % günstiger als neu

Der Umwelt zuliebe

Technische Daten


Erscheinungsdatum
07.11.2023
Sprache
Englisch
EAN
9783031347269
Herausgeber
Springer International Publishing
Sonderedition
Nein
Seitenanzahl
267
Auflage
2
Einbandart
Broschiert
Buch Untertitel
The SPARK Approach
Autorenporträt
Daria Mochly-Rosen, Ph.D., is the George D. Smith Professor of Translational Medicine, a Professor in the Department of Chemical and Systems Biology at Stanford University School of Medicine, and Founder and Co-director of SPARK at Stanford. She received her Ph.D. from the Weizmann Institute of Science, and was a postdoctoral fellow of biochemistry at University of California, Berkeley. She joined Stanford University in 1993 and served as the chair of her department for four years and then Senior Associate Dean for Research for seven years. She leads a multidisciplinary laboratory that includes basic researchers and clinicians, which recently focused their efforts on neurodegenerative diseases. In 2003, her lab’s research led to the founding of KAI Pharmaceuticals, where she served as CSO for one year, and as chair of the Scientific Advisory Committee and a member of the Board of Directors after her return to academia. She also co-founded two other biotech companies. In addition, Dr. Mochly-Rosen served on a variety of review groups including the Peer Review Advisory Committee of the NIH and the Council of Councils of the NIH.
Schlagwörter
academia, assay design, clinical trial, preclinical drug discovery, translational medicines, target product profile, repurposing drugs, vaccine development, animal studies drugs, start-up biotech, drug formulation, pharma regulatory issues and compliance
Thema-Inhalt
PNB - Medizinische Chemie, Pharmazeutische Chemie TCB - Biotechnologie PNRP - Quanten- und theoretische Chemie MKG - Pharmakologie
Höhe
235 mm
Breite
15.5 cm

Hersteller: Springer, Europaplatz 3, Heidelberg, Deutschland, 69115, ProductSafety@springernature.com, Springer Nature Customer Service Center GmbH

Warnhinweise und Sicherheitsinformationen

Informationen nach EU Data Act

-.-
Leider noch keine Bewertungen
Leider noch keine Bewertungen
Schreib die erste Bewertung für dieses Produkt!
Wenn du eine Bewertung für dieses Produkt schreibst, hilfst du allen Kund:innen, die noch überlegen, ob sie das Produkt kaufen wollen. Vielen Dank, dass du mitmachst!